News Flash 432: Weekly Snapshot of Public Health Challenges

News Flash Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

News Flash 432

Weekly Snapshot of Public Health Challenges

 

 

Pandemic Treaty & Other New COVID Initiatives Grab Center Stage At World Health Assembly

Webinar registration: The Pandemic Preparedness Treaty: Unlocking intellectual property, knowledge and know-how for the public good May 21, 2021 02:00 PM in Amsterdam, Berlin, Rome, Stockholm, Vienna

WHO: Should Members Pursue a Pandemic Treaty, In the Midst of a Global Pandemic?

‘Global health has its origins in colonialism and imperialism … it explains why IPRs are used to withhold technologies’

The decolonization of aid #1: a conversation from a historical perspective

Webinar registration: The decolonization of aid #2 – a development perspective Jun 2, 2021 04:00 PM in Amsterdam 

China and global development: seven things to read in May 

‘IP Monopoly Capitalism’ – A ‘Virus’ To Society During COVID-19 

Coronavirus disease (COVID-19) Weekly Update

More flexible storage conditions for BioNTech/Pfizer’s COVID-19 vaccine 

Big Pharma Commits to 5-Point Plan to Increase COVID-19 Vaccine Equity

Left-behind Sanofi closes in on COVID vaccine

UNICEF: The COVAX Facility will deliver its 65 millionth vaccine dose this week. It should’ve been at least its 170 millionth. The time to donate excess doses is now 

MSF: US must commit to sharing more surplus COVID-19 vaccine doses

Dear President Biden and Congress: Time for US to Lead Response to the Growing COVID-19 Global Vaccine Crisis

Tanzania committee recommends joining COVAX, reporting COVID-19 cases 

COVID-19 vaccination in India: we need equity 

Why India’s digital divide is hampering vaccine access

Mental Health Awareness Week: Who takes care of Indian health workers in the second wave?

The cold chain storage challenge 

PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia

Death in the Time of COVID by Brian Johnston 

WHO issues new guidance for research on genetically modified mosquitoes to fight malaria and other vector-borne diseases

Intestinal Worm Infection Can ‘Predispose Women To Viral STIs’

Centering Equity In The Design And Use Of Health Information Systems: Partnering With Communities On Race, Ethnicity, And Language Data

Webinar: International Arbitration and Corporate Impunity: Lessons from the Cases Chevron and RWE May 21, 2021 

Young women in the agricultural sector in Uganda: lessons from the Youth Forward Initiative 

Q&A: ‘We have biodiversity laws, it’s time to enforce them’

European Green Deal: Developing a sustainable blue economy in the European Union 

Net Zero by 2050 A Roadmap for the Global Energy Sector

Dynamic WHO dashboard for island states highlights barriers and progress on climate change and health

Successful Crop Innovation Is Mitigating Climate Crisis Impact in Africa

Climate Crisis: Elephants in the Room are Getting Nastier

 

 

 

 

 

 

 

Death in the Time of COVID

Recording and understanding the numbers of cases and deaths from COVID-19 at a local, regional and national level and how these vary over time and changing circumstances, is an epidemiological, as well as a moral imperative. However, as with many human endeavours, especially those based on good intentions, the reporting of this “truth” is never straightforward. 

And this happens at a time when death from COVID-19 has also generated challenges at a personal level including due to social distancing, lockdowns and travel restriction measures which impact on the spiritual and mental health of human beings is likely to far outlive the period of high mortality bound up with the pandemic

By Dr. Brian Johnston

Senior Public Health Specialist

London, United Kingdom

 Death in the Time of COVID

 

In many ways, COVID-19 has changed and shaped our relationship with death, both at a personal and societal level. COVID, as it is presented in the media, has understandably focussed on the physical manifestations of death – the cessation of life, the stopping of the heartbeat, the termination of electrical activity in the brain… By this reckoning the pandemic has already claimed millions of lives, each one of which is a real and personal tragedy for those involved. The daily and weekly tallies of these COVID deaths are published in macabre tables, where the misfortune of one country can be readily compared with that of another from various perspectives.

Recording and understanding the numbers of cases and deaths from COVID-19 at a local, regional and national level and how these vary over time and changing circumstances, is an epidemiological, as well as a moral imperative. However, as with many human endeavours, especially those based on good intentions, the reporting of this “truth” is never straightforward.

In some countries, the sheer magnitude of the impact of COVID on health, social and economic systems have prevented the accurate recording of deaths or made it extremely difficult. In these circumstances, there has undoubtedly been an under-reporting of the mortality associated with the pandemic. Where the infrastructure of the country was already stretched before COVID, the damage done by the virus has rubbed salt into an already open wound. Perhaps in the aftermath of COVID, the health, economic and social deficiencies highlighted by this global catastrophe can act as a catalyst to more affluent countries in their efforts to help those societies facing fundamental challenges on numerous levels. We shall see…

Under-reporting of deaths is to be regretted from a scientific perspective. Our ability to learn lessons from this terrible disease is compromised by poor or inaccurate data. Models and theories with their foundations in questionable information are like structures built on shifting sand. Theoretically, the next time we have a pandemic, the greater our knowledge and understanding; the greater our ability will be to address the new challenges and avoid making the same mistakes we made this time around. However, human beings do have a remarkable capacity for self-destruction and our decision-making processes are far from perfect and never straightforward.

In contrast, under-reporting of COVID deaths becomes sinister and divisive when the prestige of a country becomes tied to the number of deaths published. From this perverse perspective, the websites recording pandemic deaths are treated as league tables, in which the barometer of success of a state is measured by a lower tally of cases and/or deaths. The actual situation within such countries is to a large extent irrelevant, as media and official channels are used as conduits for misinformation aimed at keeping the reported numbers low. Modelling based on such data is immediately compromised and the impact from a scientific and epidemiological perspective is both immediate, long standing and perhaps irreversible.

Such dishonesty, aimed at making a country look good on the international stage is both short-sighted and counter-productive – it does a disservice to the citizens of the country in question, as well as to humanity in general.

A major barrier to effective action when addressing any problem is to deny its existence or to downplay its importance – if there are only a small number of deaths reported in a country, then those in power can justify treating COVID as a lower priority, or worse still, take measures that allow the damage to continue hidden from sight. Similarly, the ability of other states to find effective solutions to the many challenges offered by COVID is compromised by questionable or distorted data from countries consciously engaging in under-reporting of deaths.

Death from COVID-19 has also generated challenges at a personal level. Normally, the major events in life (births, marriages, funerals etc.) are marked by traditions and social gatherings. The risk of death from COVID has curbed many of these activities, which form a cornerstone of our existence and how we live our lives. Social distancing, lockdowns and travel restrictions have curtailed the way we express ourselves as social creatures. Traditions have been suppressed in the name of public health and the status quo has shifted radically to protect the population.

Whilst necessary in the short term, the impact of these measures on the spiritual and mental health of human beings is likely to far outlive the period of high mortality due to the pandemic. Similarly, the economic impact of COVID will take years to repair and in many cases the scars left by this pandemic will last a lifetime.

If we are to salvage anything positive from COVID-19 and truly learn practical and tangible lessons that will protect us in the future, we must deepen our knowledge of the disease. Any action which taints or compromises the creation of this shell of protective wisdom should be regarded as unacceptable and steps taken to neutralise the corrosive effects of such activities.

In gaining a deeper understanding of COVID-19 we are shaping our destiny and that of future generations, so that another pandemic will lead to fewer deaths and less suffering. Hope is a wonderful thing, but it must be linked to knowledge and action for effective solutions to be created.

COVID has brought us to our knees, but when its cousin arrives at our door in the years to come and reaches out a skeletal hand, we must drag it to its knees instead. Let’s hope we can…

—————————

 

By the same Author recently on PEAH

Unleashing the True Potential of Data – COVID-19 and Beyond
The myriad of data sources now available create a real challenge for even the most literate of analysts and researchers, when trying to make sense of the emerging picture of COVID-19, in real time. Against this background, it could be argued that what we now need is greater synthesis of information, where data from multiple sources is combined and refined, to improve clarity and reduce the ambient “noise” that is currently in the system

News Flash 431: Weekly Snapshot of Public Health Challenges

News Flash Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

News Flash 431

Weekly Snapshot of Public Health Challenges

 

An international pandemic treaty must centre on human rights 

Pandemic Treaty Proposal to go before WHO Member States this Week 

A New WHO International Treaty on Pandemic Preparedness and Response: Can It Address the Needs of the Global South? 

A global public health convention for the 21st century 

COVID-19: Make it the Last Pandemic. Main report of the Independent Panel for Pandemic Preparedness and Response

WHO’s work in health emergencies. Strengthening preparedness for health emergencies: implementation of the International Health Regulations (2005). Report of the Review Committee on the Functioning of the International Health Regulations (2005) during the COVID-19 Response

Report of the Independent Oversight and Advisory Committee for the WHO Health Emergencies Programme

Learning session – How can we strengthen health systems worldwide? May 18 2021 at 3PM CET

100 years after the discovery of insulin, governments and health leaders have a crucial opportunity to support a new global resolution on diabetes and insulin access

Webinar registration: Global Health governance at the crossroads: An introduction to the 74th World Health Assembly

Webinar registration: Social Participation Works: Engaging those left behind to drive UHC May 20, 2021 12:00 PM in Zurich

Porto Social Summit: all partners commit to 2030 social targets

SDSN Youth Global Youth Networks Quarter 1 report

Global Integrity Day (9 June): Corruption and Poverty

Registration: 40th Anniversary – International Code of Marketing of Breast-milk Substitutes May 21, 2021 08:00 AM in Eastern Time (US and Canada)

Webinar registration: Developing Gender-Sensitive Addiction Programmes Jun 16, 2021 01:30 PM in Amsterdam, Berlin, Rome, Stockholm, Vienna

AEPF 13 – PROGRAMME (17TH MAY TO 24TH MAY, 2021) & REGISTRATION

UNFPA: The State of the World’s Midwifery 2021 

WHO ‘needs more powers’ says independent panel co-chair Helen Clark 

WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 

Coronavirus disease (COVID-19) Weekly Update 

India reports 362,727 new coronavirus infections

WHO Upgrades Virus Mutation Driving India’s COVID Surge To ‘Variant of Concern’ – Global Cases Start To ‘Plateau’ 

Supply-chain strategies for essential medicines in rural western Kenya during COVID-19

Diseguaglianze globali al tempo della pandemia 

Excluding Refugees, Migrants & Other ‘Uprooted People’ From COVID Vaccine Campaigns Undermines Global Health & Safety 

Webinar registration: Cancel the debt: demanding debt justice for global recovery after Covid Tue, 25 May 2021 19:30 – 21:00 CEST 

EU COVID-19 SOLIDARITY PROGRAMME FOR THE EASTERN PARTNERSHIP COUNTRIES

How to Assess the Willingness of US to Suspend Patent Protection on Vaccines?

Pope Francis backs waivers on intellectual property rights for vaccines 

Chinese Sinopharm Vaccine Gets WHO Green Light – Positioning It To Resupply COVAX Global Vaccine Facility 

Bolivia seeks to import COVID-19 vaccines from Biolyse, if Canada grants them a compulsory license

ANTICOV: largest clinical trial in Africa for people with mild COVID-19 to test new drug combination 

Digital health technologies and adherence to tuberculosis treatment 

Evaluation of the 2016–2020 regional tuberculosis response framework, WHO Western Pacific Region 

Opinion: Women everywhere deserve the ‘essential 15’ for a healthy pregnancy

UN Reports Acute Food Insecurity in Southern Madagascar 

South Asia’s ‘catastrophe’, soaring food prices, and EU migration deaths: The Cheat Sheet

As pesticides poison the planet, people put into practice toxic-free food systems 

Millions at risk as cities fail to adapt to climate change: report 

European Green Deal: Commission aims for zero pollution in air, water and soil

 

 

 

 

 

News Flash 430: Weekly Snapshot of Public Health Challenges

News Flash Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

News Flash 430

Weekly Snapshot of Public Health Challenges

 

WHO calls for better hand hygiene and other infection control practices

Webinar registration: Virtual Policy Dialogue | The Revision of the EU Regulations on medicines for children and rare diseases May 20, 2021 12:00 PM in Brussels

Webinar registration: Lost in the pandemic? The pulse of global health in times of SARS-CoV-2 

Coronavirus disease (COVID-19) Weekly Update 

Biden Backs Waiving International Patent Protections For COVID-19 Vaccines

Biden commits to waiving vaccine patents, driving wedge with pharmaceutical companies

WHO Director-General commends United States decision to support temporary waiver on intellectual property rights for COVID-19 vaccines

MSF applauds US’ leadership on waiving IP for COVID-19 vaccines

Time to End ‘Delaying Tactics’ on TRIPS Waiver, Say India And South Africa Ahead Of Critical WTO Meeting

Trade barriers ‘block global COVID-19 vaccine goals’ 

EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated

EMA starts evaluating use of COVID-19 vaccine Comirnaty in young people aged 12 to 15

WHO lists Moderna vaccine for emergency use

Moderna Signs Landmark Agreement With COVAX For 500 Million mRNA Vaccine Doses – WHO Asks G7 For US$20 Billion In COVID Finance

EMA starts evaluating use of Olumiant in hospitalised COVID-19 patients requiring supplemental oxygen

Covid-19 in Africa 

Latest Covid-19 Statistics from African Countries 

COVID-19 Vaccine Rollout Kicks Off in Africa’s Most Populous Country

WHO welcomes Sweden’s announcement to share COVID-19 vaccine doses with COVAX

The Medicines Patent Pool offers its support to the WHO COVID-19 technology transfer hub

More Strokes Observed Among Young & Healthy COVID Patients – New Study Finds

Vaccination plus Decarceration — Stopping Covid-19 in Jails and Prisons

Men and COVID-19: where’s the policy? 

The health workforce crisis should be the priority in the EU’s COVID-19 Recovery

WHO Director-General congratulates the Democratic Republic of the Congo as 12th Ebola outbreak is declared over; stresses need to maintain vigilance to prevent virus’s return 

MPP generic manufacturing partners to supply low- and middle-income countries with WHO-recommended paediatric ARV formulation 

Joe Biden raises Trump refugee cap after backlash

Will the European Pillar of Social Rights Action Plan solve long-standing health inequalities?

Healthy ageing, chronic disease management

Dietary tool aims to cut disease, climate change risks

NGOs call on ADB to end fossil fuel loans amid climate reboot

Brazilian Amazon released more carbon than it absorbed over past 10 years: study 

Brazil Relies on Rainfall that Depends on the Forests 

Researchers: Climate pledges see world closing on Paris goal

 

 

 

 

 

 

News Flash 429: Weekly Snapshot of Public Health Challenges

News Flash Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

News Flash 429

Weekly Snapshot of Public Health Challenges

 

Webinar registration: Poisoned Food, Poisoned ecosystems: how people are working towards pesticides free communities May 5, 2021 02:00 PM in Paris

Webinar registration: Health cooperation in times of the climate emergency
Transformative policies – transformative practice Thursday, 29 April 2021, 15.00-18.00 hrs CEST

Event registration: MAY 06 Advancing Essential Public Health Functions to Prevent the Next Pandemic 

From “learning from the field” to jointly driving change 

IN FOCUS – Discussion paper on the Global Health security discourse – by Action against AIDS Germany and partners

Coronavirus disease (COVID-19) Weekly Update

Toscana Medica aprile-maggio 2021: un numero tutto dedicato alla pandemia

Statement by President von der Leyen, Prime Minister of Belgium De Croo, CEO of Pfizer Bourla, and co-founder and Chief Medical Officer of BioNTech Türeci, following the visit to the Pfizer manufacturing plant in Puurs, Belgium

EMA and ECDC join forces for enhanced post-marketing monitoring of COVID-19 vaccines in Europe

Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from BioNTech/Pfizer and Moderna

AstraZeneca’s COVID-19 vaccine: benefits and risks in context

UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine

MSF feedback on EU statement at WTO COVID-19 vaccine equity event

France commits to donating 500,000 vaccine doses to COVAX 

ANTICOV: largest clinical trial in Africa for people with mild COVID-19 to test new drug combination 

TDR: World Malaria Day Bulletin 26 April 2021

In Fighting COVID-19, We Can’t Neglect Malaria

Oxford team behind Covid jab develops ‘landmark’ malaria vaccine

Commission: Antimicrobial resistance among biggest global health threats 

Dealing With Ebola and Anthrax Prepared Africa for COVID-19 

Renewing the fight to end tuberculosis 

The TB ‘health crisis’ in Latin American jails 

Rapid Priority Setting in Low- and Middle-Income Countries: The Potential of Adaptive Health Technology Assessments

Addiction Should Be Treated, Not Penalized

Are Public Information Campaigns for Migrants Effective? Lessons for the Biden Administration 

UK’s aid cuts for clean water projects criticised

Brazil cuts environment budget despite climate summit pledge

Halting the Vast Release of Methane Is Critical for Climate, U.N. Says 

To Effectively Combat Climate Change, Listen and Act on Ideas from the Youth 

How to put cities at the heart of the energy transition

Why agricultural reform is needed to achieve net zero emissions

Immobility: The neglected flipside of the climate displacement crisis

 

 

 

 

 

 

 

 

 

News Flash 428: Weekly Snapshot of Public Health Challenges

News Flash Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

News Flash 428

Weekly Snapshot of Public Health Challenges

 

A Global Health Crisis To Shape a New Globalisation by Enrique Restoy

Global Health Inequity 1960-2020: EQUITY VS. EQUALITY, DIGNITY VS POVERTY, EQUITABLE AND SUSTAINABLE WELLBEING VS HUMAN DEVELOPMENT INDEX by Juan Garay, Nefer Kelley, David Chiriboga, Adam Garay 

Is ‘Bidenomics’ a watershed moment in global economics?

TDR: Monitoring and evaluating social innovations in health

Coronavirus disease (COVID-19) Weekly Update 

After encouraging statement from US on landmark COVID-19 monopoly waiver, MSF calls on all opposing countries to relent ahead of next talks

COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets

WHO: Statement on the seventh meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic

Lost in pandemic? The pulse of global health in times of SARS-CoV-2 Policy dialogues ahead of the 74th World Health Assembly, 10-13 May 2021, organized and hosted by the Geneva Global Health Hub (G2H2) 

WHO Holds First Ever Pre- World Health Assembly Session With Civil Society 

Biden Administration must take bold action to ensure global COVID-19 vaccine access

How ‘vaccine passports’ could exacerbate global inequities

Is the South African COVID variant immune to vaccines?

Is a double mutant COVID variant behind India’s record surge?

Mideast refugees left behind in COVID-19 vaccine race 

COVID-19 and risks to the supply and quality of tests, drugs, and vaccines

Antibiotics pipeline ‘insufficient’ to tackle antimicrobial resistance

Policy Cures Research: G-Finder 2020 NEGLECTED DISEASE RESEARCH AND DEVELOPMENT: WHERE TO NOW? 

COVID-19 Provides Lessons for TB Vaccine Development 

MSF supports TB survivors’ court case for Indian government to override patents on lifesaving TB drugs 

The Medicines Patent Pool partners with two generic manufacturers to scale up access to generic dolutegravir in selected upper-middle-income countries 

Supplies run low as Kenya and US standoff over HIV drugs 

Advancing President Biden’s Equity Agenda — Lessons from Disparities Work

Women’s Economic Empowerment as a US Development Priority: Still A Lot of Room for Improvement

Child Trafficking in South Asia Facilitated by Open Borders 

Creating An Agenda For Children’s Resiliency And Health 

WTO Members note sharp downturn in LDCs’ trade, discuss role of trade in eradicating poverty 

Climate change ‘has dented global agricultural productivity’

Health & Climate Activists Have High Hopes That US Climate Summit Can Open New Chapter 

Concerns over climate finance for poorer nations as White House summit begins 

Breakthrough as EU negotiators clinch deal on European climate law

Giving plastic waste a new life

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Global Health Inequity 1960-2020

Health is the most cherished human aspiration across cultures and time. The only global health objective agreed by all countries is the constitution of the World Health Organization, which aims at the “best feasible level of health for all”. With international data - from 1960-2020- we identified such “best feasible level of health” and selected countries with good health (life expectancy above world average) and also economic and ecologic conditions that are replicable for all, including coming generations. The identified models question the prevailing concepts of development and poverty thresholds. Using healthy, replicable and sustainable (HRS) models, we are able to adjust mortality rates by age and sex published by the UN Population Division every five years. The excess mortality above that from the HRS models is the burden of health inequity, a powerful indicator for socioeconomic justice. It also allows setting the “dignity threshold” (below which no country has achieved that best feasible health) and the equity curve, between such minimum and the maximum “excess level” above which global equity and sustainability is not feasible, and wellbeing  neither improves for those in that hoarding end. Accumulation above that threshold and carbon emissions above the “ethical threshold” above which we are bound to irreversible global warming > 1.5 degrees, has a price on life years lost in others, which we factored in an “equitable and sustainable wellbeing” index. The world could save 16 million lives lost every year to inequity with only half the GDP present levels and preserve the lives of coming generations, including by investing the unnecessary surplus into global public goods. Such shift to equity requires a change in values and a redistribution of some 7% of GDP, only 10% of the GDP above the unnecessary and unethical excess threshold.


“Enough is enough and more is too much”

Mahatma Gandhi 

credit: WHO

Global Health Inequity 1960-2020 

EQUITY VS. EQUALITY, DIGNITY VS POVERTY, EQUITABLE AND SUSTAINABLE WELLBEING VS HUMAN DEVELOPMENT INDEX

 

By Juan Garay*, Nefer Kelley**, David Chiriboga***, Adam Garay****

*Professor of Bioethics, Chiapas University, Mexico

**Bay area Community Resources, Berkeley, California

***University of Massachusetts, USA

****Sustainable Health Equity Movement

The views in this study and document do not necessarily reflect the positions of the organizations related to its authors

 

Scene setting

When the world was recovering from the major wars stemmed in Europe, it resolved to create system where all countries would preserve peace and respect human rights. Until then, just a handful of countries had taken the German Von Bismarck XIX century health care model from workers to the general population through universal health care systems. Norway and Sri Lanka[i] in the 30s and Costa Rica[ii] in the early 40s had committed to universal free health care. In the mid-40s, the Universal Declaration of Human Rights[iii] brought hope and a sense of brotherhood in a world ravaged by cruel massive wars, including its final blow of the nuclear bombs. Its article 25 declared the right of health and wellbeing, including through social protection. In parallel, the World Health Organization (hereafter WHO) defined health as a state of physical, psychological and wellbeing and its article 1 committed all member countries to strive for the “best feasible level of health for all peoples[iv]. The 60s witnessed the wave of African independence broke the last colonial chains that had lasted four centuries while the WHO managed to coordinate the efforts to eradicate smallpox. The 70s brought the international covenants on human rights and although they were legally binding, the states were meant to protect and promote human rights in a “progressive” way[v], that is, according to their means. It was by the end of the 70s that the declaration of Primary Health Care in Alma Ata[vi] renewed hopes and a sense of partnership for the right to health through civil society, the United Nations and countries throughout the world. However, little did it last. The oil crisis brought another dimension to the cold war, the dollar delinked with gold reserves; the Washington consensus hand in hand with the Bretton Wood institutions -created to rebuild from the wars- influenced countries to “structural adjustments” and reduce the size of the state and let the major capital powers, multinational and financial banks, to expand their businesses globally. The World Bank gradually “took over”[vii] the influence of health policies through loans subject to social spending cuts and tax exemptions to major economic powers, which from the 90s, hold most governments in their grips. Twenty years after the hopes of health for all from Alma Ata, Primary Health Care became “selective”[viii], health services became restricted to “cost-utility” (measured through the burden of disease tool of the World Bank) interventions (WB, Investing in health)[ix] and health financing was set at some meagre levels for low income countries by the commission on macroeconomics for health[x] . All were recipes of bankers for the poor countries to survive and lift from extreme poverty of under-one-dollar-a-day[xi] yet under much lower life expectancies than those feasible for all. The last decade of the century was further shadowed with the AIDS pandemic[xii] and the even less visible health impact of the collapse of the Soviet Union[xiii]. Globally life expectancy continued to slowly increase thanks to the counterbalance effect of the health gains of the most populous country in the world, China[xiv]. By the turn of the century, the Millennium declaration focused three out of their eight Millennium Development Goals  on health but, not surprisingly after two decades or restricted and selective health care, they focused on either population groups (maternal and under 5 mortality) or diseases (tuberculosis, malaria and HIV/AIDS). In parallel almost on one payed attention to the upgrade of the right to health in the international covenant of economic, social and cultural rights[xv]. The Global Fund to fight those diseases, responsible for some 20% of the global burden of disease, gathered more funding than the WHO itself, whose funding became gradually tailored to those and other vertical interventions[xvi] financed by Western development agencies, the Pharma foundations and philanthro-capitalism, in close connection with the former[xvii]. The following decade claimed advances in rolling back those diseases but it soon became clear that health systems, after three decades of de-funding and brain drain, were unable to sustain the donor-funded vertical cooperation programmes. By the end of the first decade of this century the Commission on Social determinants for Health[xviii] exposed the deep connections of socioeconomic inequities and the right to health, while the Rio+20[xix] in Brazil revealed the grim horizon of climate change. However, the massive economic powers, held in fewer hands playing financial speculation globally, fuelled a global economy based on scale production and blind consumption. Countries’ and their citizens’ debts were managed by the same financial powers that ruled over the interest rates of treasury bonds, vital for all countries to keep their services running. Health was not an exception and it was progressively fragmented and privatised[xx]. The world clearly entered its second decade of the present century with growing inequalities and global warming, hijacking the future of coming generations. The cold war had changed to a torrid stage, “a war with no guns”, with far more damaging impacts[xxi]. The 2015 MDG target date arrived while the world reinvented its goals in the 2030 agenda including the objectives of equity (“leave no one behind”)[xxii] and preserving nature (most urgently limiting carbon emissions). That very year the world met in Paris and agreed on Humanity’s main challenge: rolling back climate change and avoiding the 1.5-degree/increase from preindustrial levels[xxiii], a point-of-no-return that would, and most probably will, trigger feedback loops of nature degradation and human and all-life suffering in our ill-treated planet. However, the goals of greater intra-generational (socioeconomic justice) and inter-generational (environmental justice) equity were far from ambitious[xxiv]. Equity in SDG 10 merely aimed at a greater growth (even 0.0001 %?) in the lowest 40% income group than the average (allowing for the exponential wealth capture of the 1% and the 1% of them)[xxv]. Carbon emissions in the Paris initial commitments targeted low reduction levels that would not prevent irreversible and catastrophic global warming before mid-century. The last five years saw further rupture of multilateral commitments to preserve life in our planet, including ours, with US President Trump’s denial of climate change, growing carbon emissions and global warming, loss of biodiversity and progressive stress on other planetary boundaries as surface water, forestland, sea pH, phosphorus and nitrogen cycles[xxvi]. The stress on nature and the high levels of human mobility and trade related to globalization, led to the present Covid-19 pandemic[xxvii] and revealed the dominance of the global market.  The present framework shows the absence of global solidarity and frameworks to collectively share knowledge, produce and distribute global public goods[xxviii] that may equitably preserve human life and roll back this and most likely coming pandemics.

Elusive health equity

Ten years ago, the World Health Assembly welcomed the Report on social determinants and health, and countries committed to measure their levels of health inequity[xxix]. The WHO developed an online health equity monitor[xxx]. Equity became a term used widely and in all languages, even at a higher rate than equality. In the last ten years, though the use of the term seemed to decrease –see figure 1 on n-gram viewer counts screening over 8 million books -.

Figure 1 : N-gram viewer counts of equity vs equality

The use of the term “equity” is also subject to interpretations. Interestingly, while the Latin original word relates to fairness its use in economy has been associated to the individual shares of profits through financial speculation, one of the main dynamics leading to inequities. In health, both the WHO, most countries, civil society and academia, have measured equity through inequalities in exposure to risks, access to services or health outcomes leaving the open question of what is fair or not, to interpretation or even political visions, interests or marketing. That is how the MDGs set arbitrary targets of under-five or maternal mortality reductions, or the present SDGs opted for addressing inequalities –and in a very marginal way as above mentioned- rather than inequities. So the main question remains: what is fair and what is unfair?[xxxi]. While it is subject to cultural norms, moral references and ideologies, from the ethical point of view “a collective goal which is feasible for all can set a minimum threshold of fairness”. In health, the only internationally agreed common goal is the WHO constitution, which article 1 states that all countries will strive to “the best feasible level of health for all peoples”, that is, health equity. However, the “best feasible level of health” has not been identified and, hence, the level of health equity or inequity has never been measured. As mentioned above, the World Bank developed the metrics of burden of ill health[xxxii] and did so by comparing the effects of risk factors and diseases on premature deaths and disability with the best levels of health in terms of healthy life expectancy (enjoyed by Japan in the last two decades). However, is that “best” “feasible for all”? Certainly not in terms of the use of economic means and natural resources. This applies as well to all high-income countries and the OECD group of “developed economies” championing “development” models and “development aid”[xxxiii]. In the same line, the United Nations way of assessing progress by the “human development index” (HDI)[xxxiv] puts a significant weight on income and monetary flows (measured by GDP pc). As a consequence, it grants the highest scores to countries, which use economic means far above the world´s average (hence not replicable) and through production (even if gradually externalized), and consumption patterns incompatible with preserving natural cycles for coming generations. Had the whole world “enjoyed” the wellbeing of countries with highest HDI with their levels of carbon emissions, just to name one of the planetary boundaries under human stress, global warming would be today almost incompatible with human life. So, how can we aim at defining “best feasible level of health”?

Health equity metrics

Selection of healthy, replicable and sustainable models

Since 2011 we have been trying to define the best levels of health which are feasible today and will remain so, that is, sustainable, for coming generations. Overall, people and their forms of associations, organize their collective lives through laws, knowledge and means. While knowledge and laws aim at constant advancement and universal rights, means are limited in natural sources and economic flows, inter-related between them. We looked for healthy and feasible (and sustainable) country references. We tried to avoid the arbitrary thresholds or goals as previously set with international poverty thresholds, MDGs, SDGs and others. We then chose health, economic and ecological indicators available at national averages since 1960 from World Bank, UN and WHO sources. To select “healthy” models we chose those with constant levels of life expectancy above world average. Among them, we looked for those constantly using economic means in a globally replicable way, measured in GDP pc below world average. Within that group, we identified countries with carbon emissions pc below the “ethical threshold” which would lead to 2 degrees of global warming during the XXIst century. The analysis then found 14 countries which met the above-mentioned three criteria (Healthy, economically Replicable, ecologically Sustainable: HRS)[xxxv] constantly from 1960 to 2010 : Albania, Armenia, Belize, Colombia, Costa Rica, Cuba, Grenada, Saint Lucia, Saint Vincent, Georgia, Paraguay, Sri Lanka, Tonga and Vietnam. Five years later, we refined our selection of healthy references introducing sex disaggregation in life expectancy and the burden of disability through the healthy life expectancy indicator. To select economically replicable models we looked not just at GDP pc but also GNI pc and not only in constant value but also in purchasing power parity (PPP).  By that time, the International Panel on Climate Change (IPCC) updated the threshold of global warming “point of no return” at 1.5 degrees over pre-industrial levels, and so we adjusted the “ethical threshold”. As a result, our selection of “HRS” countries in 2016 ruled out half of the 2011 HRS models, remaining only seven countries, which met the updated HRS criteria: Armenia, Colombia, Costa Rica, Paraguay, Sri- Lanka and Tonga[xxxvi]. Most of the countries dropped off the previous list did so due to carbon emissions above the ethical threshold. In our latest analysis hereby presented, we again looked at constant HRS models introducing three new indicators: wealth pc in economic replicable models (R), bio capacity pc, and ecological footprint consumption pc below world’s bio capacity average selecting ecologically sustainable (S) models beyond the carbon emissions. The trend of the previous list of countries (trespassing the carbon emission threshold in most cases and in others, as Costa Rica, the GDP pc) led to the selection of only one HRS country. In fact, that only HRS country 1960-2020 was also the only one to meet all criteria, including the latest introduced on bio capacity and ecological footprint, during the last 2010-2020 decade. That country is Sri Lanka.

Figure 2 : Sri Lanka life expectancies vs thresholds (world averages)

Figure 3: Sri Lanka GDP and GNI pc (CV and PPP) vs. thresholds (world averages)

Figure 4 : Sri Lanka carbon emissions and ecological footprint pc vs. thresholds (world bio capacity pc average)

Obviously international data have many limitations: the reliability of those statistics varies widely between countries and the average does not reflect the subnational often-heterogeneous reality, especially in large countries. We looked at subnational data -where available- and identified subnational regions, which met HRS criteria. Data are more limited across countries and time- periods on health and economic indicators. We found no official data on carbon emissions pc at subnational levels and we used the international correlation between GDP pc and carbon emissions. Using only those three indicators and often only available for less than a decade, we found large subnational regions in China (Shanxi, Guangxi, Anhui, Sichuan and Henan), India (Kerala), Russia (Ingushetia and Chechnya) and Brazil (Alagoas, Praiba, Ceara, Para, Bahia and Rio Grande). None of the EU, USA and Japanese subnational regions were ecologically sustainable. Ideally, the analysis of HRS indicators at subnational and sub-regional levels would increase the sensitivity in finding more HRS populations with healthier, more economically efficient, and ecologically sustainable features.

The burden of health inequity

Following the ethical argument of equity stated above (feasible common goal = moral imperative) in coherence with the WHO foundational objective (best feasible health for all) and the identification of such feasible and sustainable health models (for now at national level), we could calculate the burden of health inequity, that is, the unfair and preventable (in relation to feasible and sustainable models) loss of human life. The HRS models served as the reference mortality rates and so we could estimate the expected mortality in all countries if they enjoyed such –feasible and sustainable- rates (adjusted mortality rates). The net burden of health inequity excess of observed mortality in relation with the HRS-expected on.  As the UN Population Division publishes data on population and deaths by country, sex, age (5-year age groups) and country as 5-year annual averages, we have been estimating the burden of health inequity for the last decade for the periods 1960-2010, 1960-2015[xxxvii] and –hereby- 1960-2020. Using the first set of HRS –simplified- criteria (3 by 50 years and 198 countries : some 30,000 data) and 14 HRS reference countries till 2010 and the population and mortality data by 5-year periods and country/sex/age groups (some 80,000 data), the annual net burden of health inequity (nBHiE) evolved from some 23 million in 1960 to some 16 million in 1970 and was stable thereafter at that level –with some increase in the 90s (due to the AIDS pandemic and the collapse of the Soviet Union)- till 2010[xxxviii]. When we applied updated and refined HRS reference data in 2015 we found similar results with slightly lower nBHiE in the 60s and higher (around annual 17 million) in the last decade. At that point, we looked at sub-regional (European Union) and sub-national (China, India, USA, Russia and Brazil) data to identify –as mentioned above- HRS states and provinces, even counties in some cases, and estimate national nBHiE. When applying lower level/size and larger sample units in the analysis, we found enhanced sensitivity in detecting nBHiE in the regions and countries with life expectancy above world average. For instance, with the caveat that no NUTS region in the EU were ecologically sustainable, the ratio of nBHiE ref global HRS vs. nBHiE ref. sub-regional HR(S) was > 0.11. In the analysis of the data adjusted to refined HRS criteria and references (Sri Lanka) and updated until 2020, the nBHiE in the last five years remained at some annual 16 million. Figure 5 shows the different estimates of the nBHiE by the evolving HRS criteria and updates by the 5-year period UN Population data. The divergence of the most recent HRS methodology in the 1996-2000 period relates to the peak of victims of the Sri Lanka war, which in total meant some 100,000 casualties, mainly adult men. Hence, the under-estimate of the global burden of health inequity by the end of the century compared with the previous methodologies and results where a larger group of countries diluted individual circumstances in each of them.

Figure 5: nBHiE by the evolving HRS criteria and country references

As population size and demographic structure conditions the nBHiE and disables its comparison between countries, periods of time sex and age groups, we estimated the proportion of deaths, which were due to health inequity by dividing the nBHiE by the total number of deaths. We called it the relative burden of health inequity (rBHiE). As Figure 6 shows, such proportion of unfair/preventable deaths has decreased slightly in the last 5 years but remains close to one third of all deaths, a level with only minor variations since the 70s. The rBHiE is higher in women than men and such gap has increased since the turn of the century.

Figure 6 : World's rBHiE 1960-2020

We applied the same analysis to age groups and found, as Figure 7 shows, that the relative burden was higher in younger age groups and women had their higher share of inequity than men in the reproductive age groups.

Figure 7: World's rBHiE 1960-2020 by sex and age groups

The former analysis emerges from interactive pivot tables and maps of all countries and main geographic and economic regions based on algorithms calculating nBHiE and rBHiE data by 5-year period (1960-2020), sex, 5-year age groups. They form a set of close to 500,000 data which will be shortly on line and interactive to search and compare the burden of health inequity across countries, time and demographic variables.

Health and economic inequity

Another dimension of our analysis is the link between the burden of health inequity and the unfair distribution of economic inequality (“equinomics”). By the very concept and methodology of the selection of HRS models, those countries with lower levels than the HRS GDP pc have a lower life expectancy and the highest burden of health inequity. We therefore called the HRS GDP/GNI pc (CV or PPP) the “dignity threshold”. In contrast with the poverty threshold set by the World Bank (at present daily $1.9 pc) the dignity threshold enabling feasible and sustainable life expectancy stands now at daily $10.8 pc, 5.7 times higher. We then looked at the level of GDP pc above which no country has had -along the study period- levels of sustainable ecological indicators (carbon emissions and ecological footprint), which was almost symmetrical with the dignity threshold above the world average GDP pc and we called “excess threshold”. Interestingly, just four countries of over one million inhabitants (Japan, Switzerland, Italy and Spain) had life expectancy above Greece, with GDP pc below the mentioned excess threshold. Moreover, when exploring the sub-national regions’ life expectancies we found regions in Greece, Cyprus, Italy and Spain, with GDP pc lower than the excess threshold and life expectancies higher than the country with highest levels (Japan), notably Ipeiros, in Greece (GDP pc 14,600, life expectancy 84 years). Hence, GDP pc above the mentioned excess threshold of some daily $50 pc is not required for better health. In fact, most countries with higher GDP pc have lower life expectancies than Greece and the mentioned regions. Furthermore, higher levels of GDP pc accumulates resources in detriment of the deficit areas disabled to the right to health, and is unsustainable with the sustainability of natural resources, hence the health of coming generations.

The dignity and the excess thresholds above described set three “equity zones”: deficit, equity and excess. The majority (84%) of the nBHiE takes place in countries in the deficit zone, home –see below- to almost half of the world’s population. Countries with average GDP pc higher than the HRS reference have a degree of burden of health inequity revealing health inefficiencies or internal inequities in comparison with the HRS standard. Three fourths of the nBHiE in the equity zone takes place in China, Russia, South Africa, Brazil and Mexico.

Figures 8 and 9 show the contrast of the distribution of the world’s population and GDP according to the deficit, equity and excess zones. While only some 15% of the world’s population lives in countries in the excess zone, they accumulate almost 70% of the GDP. We also looked at wealth and the distribution was even more skewed, with the excess 15% population owning over 80% of the world’s estate, goods and capital.

Figure 8: World population by countries' equity zones

Figure 9: World GDP by countries' equity zones

The redistribution required to enable the entire world’s population to have at least the dignity threshold’s spending capacity would be 7.75% of the world’s GDP (vs. the OECD DAC 0.7% commitment) which is just 10.6% of the excess GDP (unnecessarily) above the excess threshold.

Health inequity and the ecology

The world’s national borders already pose a major inequity in terms of access to natural resources.  Figure 10 shows how in fact the countries with lower access to economic flows (GDP pc), in the deficit zone, also have a low bio capacity pc. We are, therefore, born already with skewed opportunities to enjoy the universal right to health.

Figure 10 : Bio capacity pc by populations in countries' equity zones

As figures 11 and 12 show, all countries in the excess zone have ecological footprint and carbon emissions pc, which are, if generalized, unsustainable with the turnover of natural resources. Even in the equity zone, the average of ecological footprint pc surpassed the ethical threshold in the last decade while the one for carbon emissions did so already in the 90s. In the case of carbon emissions, the level of cumulative carbon emissions pc of excess zone countries, from the industrial revolution until present days, would have already meant over 5 degrees of global warming and render unliveable most of the world, especially the tropical zones colonized by those polluting powers and decimated from their natural resources.

Figure 11: Ecological footprint by equity zones vs. ethical threshold

Figure 12: Average carbon emissions by countries' equity zones vs. ethical threshold

According to our analysis, the present level and trend of carbon emissions will lead to the 1.5-degree warming above pre-industrial levels before 2050. If that trend prevails, increased temperatures will mean an excess mortality of 220 million. The distribution of such excess mortality, more than three times the suffering by the world wars in the XXth century reveals the most perverse inequity : it will take place mainly in the second half of the century, in those over 60 years of age (millennials born after 1990) and in the less polluting countries in tropical regions.

HDI vs. Health holistic index

When we measure development indicators, we look at individual wellbeing, based on the western philosophy, which grants to each human life the highest value and so has championed universal human rights, including the right to health. As we have seen in the analysis of the burden of health inequity of the last 60 years, large inequities in natural and economic resources result in high levels of burden of health inequity within pour generation and between ours and the coming generation (due to global warming). We therefore looked into the negative impact on others of excess accumulation of resources (preventing equitable distribution and maintaining half the world in the deficit zone incompatible with the right to health) and of excess carbon emissions (leading to growing excess mortality in the coming generations). We estimated the life years lost due to the burden of health inequity in countries in the deficit zone (with unmet basic condition of the dignity threshold of resources). We then calculated the excess GDP above the excess threshold (above which health and wellbeing does not improve). The relation between both resulted in around one week life lost per annual GDP pc 1000$ above the excess threshold. We did a similar analysis for the life years to be lost due to global warming and the relation with excess carbon emissions above the ethical threshold. The result was of two life days lost per annual excess CO2 ton above the ethical threshold. We deducted from the individual life expectancy at birth in each country the annual negative impacts of excess GDP pc and excess carbon emissions pc, to calculate what we call “equitable and sustainable wellbeing(ESW) (including individual wellbeing void of negative impact on others).

The countries with highest ESW were Costa Rica (the highest, with 77.7 years) followed by Cuba, Greece, Albania and Uruguay. None of them is fully economically replicable and/or ecologically sustainable but falls within the equity curve and has committed to reduce carbon emissions below the ethical threshold. We compared our assessment with the UN Human Development Index (HDI). The HDI grants, besides life expectancy and education years (which correlates with the former), high value to GDP pc with no limit (and calls it “a decent standard of living”), mimicking the dominating concept and dynamics of capitalism (constant growth and accumulation). Consequently the countries with highest ESW rank moderate in the HDI rank while those with the highest HDI rank among the lowest in the ESW due to their negative impact through excess GDP pc and excess carbon emissions.

Country HLI 2018 HLI rank HDI 2018 HDI rank
Costa Rica 77.72 1 0.81 62
Cuba 76.83 2 0.78 70
Greece 76.29 3 0.89 32
Albania 76.12 4 0.80 69
Uruguay 75.94 5 0.82 55
Chile 75.94 6 0.85 43
Panama 75.69 7 0.82 57
Lebanon 75.41 8 0.74 92
Croatia 74.95 9 0.85 43
Montenegro 74.81 10 0.83 48
Table 1: Top countries in Equitable and Sustainable Wellbeing (ESW) vs. HDI and rank
Country HLI 2018 HLI rank HDI 2018 HDI rank
Norway -1.30 183 0.96 1
Ireland 3.43 182 0.96 2
Switzerland -7.24 184 0.96 2
Hong Kong 40.29 167 0.95 4
Iceland 8.47 180 0.95 4
Germany 39.75 169 0.95 6
Sweden 31.69 175 0.95 7
Netherlands 33.59 174 0.94 8
Australia 25.44 176 0.94 8
Denmark 23.17 177 0.94 10
Table 2 : Top countries in Human development Index vs. ESW value and rank
Conclusions

Our analysis of global health equity has been challenging for a decade the prevailing concepts of development, poverty threshold and health equity, and their related metrics.

With the preliminary findings of our third analysis hereby outlined, we have fine-tuned criteria of wellbeing-health, economic feasibility-replicability and ecologic sustainability and updated to the period 1960-2020 demographic data. The results, in the midst of the Covid-19 pandemic, adding more global inequity[xxxix], lead us to reaffirm our challenge to the above-mentioned mainstream concepts, in our opinion, detrimental to the universal right to health and health equity.

The main findings from the latest global analysis of health equity are as follows:

1.-the concept of equity, that is, fair inequality, requires the definition of feasible levels of the agreed common goal (health). The 73-year old (same as world average life expectancy now) constitution of the World Health Organization states this concept (best feasible levels for all) in its founding constitution. While best health levels are identified to estimate the burden of ill health and economic indicators as cost-utility, often guiding major decisions on priorities and strategies, best feasible (and sustainable) levels have not been identified and used at national nor international levels. WHO continues to monitor health equity, ten years after the resolution on social determinants for health, by estimating health inequalities (by stratifying variables of income, education or rural/urban settings) and only in certain age groups (children and pregnant women) and some countries, (low and some middle income countries) based on household surveys with limited representability and time-frequency. Through our studies during the last decade, we continue to propose the definition of best feasible (and sustainable) health levels which enables the estimates of net and relative burden of health inequity. We propose this methodology, improved and developed at national and subnational levels, as a critical indicator of the realization of the universal right to health and a powerful barometer of international and national justice.

2.-the number of countries meeting the evolving (fine-tuned with health sex disaggregation, economic and ecologic dimensions) criteria of replicable and sustainable health-wellbeing from 1960 has been decreasing from fourteen till 2010, to seven till 2015 and only one till 2020, possibly the last year when we may identify countries that have steadily met the mentioned criteria.

  1. – for the last forty years, the net-burden of health inequity (nBHiE) has been fluctuating between 18 and 16 million deaths and the relative burden of health inequity (rBHiE) remained almost stagnant around 30% with a slight reduction since the turn of the century. Such reduction rate has been lower for girls and women and they suffer significantly higher levels health inequity, especially in the reproductive age groups. Children and youth have higher rBHiE although older age groups have gradually increased their rBHiE with time. Our interactive database (updated with the recent data hereby outlined) allows the comparison of the net and relative burden of inequity between periods, countries, sex and age groups. When such analysis is done at subnational level, as we have attempted in the last years in a number of countries, the mapping of the burden of health inequity and demographic features may guide economic, social, fiscal and territorial cohesion/equity targets and strategies.

4.-the HRS reference models define a “dignity threshold” below which no country has, now for sixty years, been able to enjoy a level of life expectancy at birth, for women and men, feasible and sustainable for all. Such dignity threshold, presently at some 10$/day, is more than five times higher the “poverty threshold”. One third of the world’s population lives between the poverty and the dignity threshold, has no chance to enjoy the right to health and remains neglected by economic and cooperation approaches led by the concept and threshold of poverty.

  1. – The prevailing development concepts and references are deeply intertwined with the mainstream economic dynamics ruling the international and national policies and lifestyles. It avoids setting any limit to economic flows, growth and accumulation. In fact, it grants the highest human development index to the countries with highest GDP pc called (the higher the better) “decent (?) standard of living” which, if generalized, would require several planets in terms of natural resources to be replicable and sustainable. Contrary to this dominant paradigm, excess accumulation of economic flows and wealth is one of the main root causes of health inequity as it prevents equitable distribution of resources while it is ecologically unsustainable and, above the excess threshold, does not improve individual and collective health. We therefore propose an equitable and sustainable wellbeing index, which takes into account the individual conditions counterbalanced with the negative impact on others through excess accumulation and nature degradation. The countries with highest HDI rankings are among the lowest in the ESW index and this fact merits a debate around the concepts and metrics guiding development.

6.-We define the “equity curve” as the distribution of the human population according to their GDP pc capacity, between the above-mentioned dignity threshold a centre around the average and a symmetric “excess threshold”. It allows best subnational levels of life expectancy within the equity curve, economically replicable models to gradually improve its efficiency in translating shared knowledge and resources into wellbeing and a sustainable use and recycling of natural resources to allow intergenerational health equity.

Figure 13: Equity curve and thresholds

 

Acronyms

HRS : healthy replicable and sustainable

BHiE : Burden of health inequity

nBHiE : net burden of health inequity

rBHiE : Relative burden of health inequity

WES : Wellbeing in equity and sustainability

 

References

[i] https://www.ncbi.nlm.nih.gov/books/NBK316260/

[ii] https://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S1409-14292013000200003

[iii] https://www.un.org/en/about-us/universal-declaration-of-human-rights

[iv] https://www.who.int/governance/eb/who_constitution_en.pdf

[v] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394996/

[vi] https://www.who.int/publications/almaata_declaration_en.pdf

[vii] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1449852/

[viii] https://pubmed.ncbi.nlm.nih.gov/114830/

[ix] https://pubmed.ncbi.nlm.nih.gov/10619685/

[x] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2567724/

[xi] https://www.researchgate.net/publication/46511466_Dollar_a_Day_Revisited

[xii] https://pubmed.ncbi.nlm.nih.gov/9677187/

[xiii] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1116380/

[xiv] https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-018-5112-7

[xv] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394996/

[xvi]https://www.researchgate.net/publication/228449096_Vertical_funds_in_the_health_sector_Lessons_for_education_from_the_Global_Fund_and_GAVI

[xvii] https://journals.openedition.org/faceaface/745

[xviii] https://www.who.int/social_determinants/thecommission/finalreport/about_csdh/en/

[xix] https://sustainabledevelopment.un.org/rio20

[xx] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052329/

[xxi] http://www.peah.it/2018/07/5498/

[xxii] https://unsdg.un.org/2030-agenda/universal-values/leave-no-one-behind

[xxiii] https://www.ipcc.ch/sr15/

[xxiv] https://scitechdaily.com/the-truth-behind-the-paris-agreement-climate-pledges-insufficient-to-address-climate-change/

[xxv] https://www.cesr.org/disparity-dignity-inequality-and-sdgs

[xxvi] https://www.stockholmresilience.org/research/planetary-boundaries.html

[xxvii] https://ideas4development.org/en/pandemics-environmental-origins-covid-19/

[xxviii] https://www.who.int/bulletin/volumes/81/7/en/Smith0703.pdf

[xxix] https://www.who.int/social_determinants/implementation/en/

[xxx] https://www.who.int/data/gho/health-equity

[xxxi] https://pubmed.ncbi.nlm.nih.gov/16533114/

[xxxii] https://olc.worldbank.org/content/global-burden-disease

[xxxiii] https://www.oecd.org/dac/thedevelopmentassistancecommitteesmandate.htm

[xxxiv] http://hdr.undp.org/en/content/human-development-index-hdi

[xxxv] https://www.sciencedirect.com/science/article/pii/S0033350617301610

[xxxvi]  https://oxfordre.com/publichealth/view/10.1093/acrefore/9780190632366.001.0001/acrefore-9780190632366-e-62?rskey=mI3ffX&result=2

[xxxvii] https://www.dodax.fr/fr-fr/livres-et-livres-audio/medecine-generale/d-chiriboga-n-kelley-jm-ramos-reviewers-the-ethics-of-health-equity-global-burden-of-health-inequity-trend-from-1950-and-prospects-in-the-xxist-century-dp4HG0BMF3L35/

[xxxviii] https://www.binasss.sa.cr/eng.pdf

[xxxix] https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31145-4/fulltext

 

A Global Health Crisis To Shape a New Globalisation

After major crises and wars, the world tends to recompose itself. One such crisis is Covid-19. The pandemic is exposing deep inequalities within and between countries that question the current model of globalisation. 

This piece argues that the pandemic is so widespread and disruptive that it is bound to bring significant changes in the world order. Covid-19 is already altering the balance of powers in global health, provoking a rethinking of a new legal and policy framework to prepare and respond to future global health threats, and inspiring a popular movement to treat global health as a global public good. 

A critical question is whether these changes will combine to address economic, environmental, and social inequalities rendering globalisation more legitimate, transparent and accountable; or whether the new order in global health will perpetuate inequality

By Enrique Restoy, PhD

Head Evidence: Frontline AIDS

Associate Researcher: University of Sussex, UK

erestoy@frontlineaids.org 

A Global Health Crisis To Shape a New Globalisation

 

Ironically, the biggest global health threat since AIDS might have certified the demise of globalisation as we know it.

We have witnessed a fragmented, disorganised and unequal response to the Covid-19 pandemic.

Can you recall any special session or resolution by the UN Security Council or the G-20 on the pandemic? Do you know what the World Bank or the International Monetary Fund did over the first months to help countries prevent the epidemic from becoming a pandemic with massive economic impact?

As the pandemic broke out, essential supplies such as ventilators and PPE were sold to the biggest bidder, with supplies turning last minute to whatever country paid the highest price. Big pharmaceutical companies rushed to develop vaccines with public funding from Western states that pre-ordered the vast majority of doses. It took months to set up the global initiative on vaccines (COVAX). The initiative will only deliver widespread distribution of vaccines to most low-income countries well after they have reached most people in the rich ones.

Governments constantly undermined World Health Organisation’s guidelines, imposing their own versions of what measures needed to take place. For months, Sweden allowed near normal life, while the rest of Europe was confined. For a few days, the US banned travel from Europe, but not from the UK, apparently because the UK government was a friend.

The coronavirus also provided the perfect canvas for nationalists and populist to show their true colours.

Brazilian president Jail Bolsonaro, first denied out rightly that there was even a pandemic killing hundreds of thousands of Brazilians. Then he told his people to ‘toughen up’. Late Tanzanian president, John Magufuli, rejected vaccines and invited the population to pray instead.

Some countries expelled migrant workers who had lost their jobs due to the pandemic thus fuelling discrimination against returnees in their country of origin.

This pandemic has indeed erased any belief that our globalised world was equipped to deal with a major planetary crisis.

Globalisation as we knew it

Since the end of WWII, globalisation has increasingly opened international borders to the exchange of goods, services, finance, people and ideas. It created institutions and policies at global and national levels to facilitate such movement.

Both neo-liberals and conservatives on one hand, and progressive thinkers on the other, loved to hate globalisation. But loved it somehow.

For the neo-liberals, globalisation broke down trade barriers, expanded the power of multinational corporations, and protected the global financial sector during economic crises, bringing the biggest global economic growth in GDP terms in history.

Any young graduate from a middle-class background in the rich West could choose in which country to work, where to go the next weekend on a city break abroad, what new gadget to buy that would be home in a matter of hours. A life of opportunity and open doors. Alas, not for all.

For the progressive proponents representing the interests of the most marginalised, globalisation brought about a strong human rights system underpinning its universal values, epitomised by the Human Rights Council, which since 1989 has periodically scrutinised the human rights record of almost all countries on the planet.

Globalisation made possible an unprecedented global health response to HIV and AIDS with its own global governance facilitating the access to affordable lifesaving treatment to now over 24 million people living with HIV across the world.

Globalisation framed the Millennium Development goals (MDGs), a set of state commitments that have led to a drastic reduction in maternal and child mortality and severe poverty, and a dramatic increase in girls’ access to education and among other huge advances in human development over the past few decades.

The Sustainable Development Goals (SDGs) which replaced the MDGs went further to underpin the respect for human rights in the pursuit of development; and the Paris Agreement represents a legally-binding recognition by many states that they need to take decisive action against climate change.

There were therefore positives in globalisation from all perspectives of the development debate.

Covid-19: globalisation as it really is

Anti-globalisation sentiment however, has been strong and mounting in the past few years. Although it traditionally came from the left side of the argument, it has also been highly criticised by the right.

The coronavirus and its inadequate response across the globe has exposed most brutally and to most people two critical problems globalisation has exacerbated to perhaps, a point of no return: inequality in treatment and opportunities, and an insatiable pursuit of economic growth to the detriment of the Earth’s limited resources.

These two problems are interdependent. Without strong social protection systems and measures to address inequalities in society, economic growth tends to multiply such inequalities while destroying the environment. And vice versa, societies with large inequalities need much greater economic growth to reduce poverty, thus decimating the Planet even further. Inequality hurts economic growth and the Earth.

However, across the globe, the quest for economic growth has meant weaker policies to ensure a more equitable distribution of wealth, and inadequate measures to reduce the environmental impact of such growth. Globalisation contestation has failed to stop this self-destructive trend.

But Covid-19 has had an unprecedented impact on the entire notion of globalisation. It has brutally exposed the underlying inequalities of globalisation both in the more economically developed countries and in the less economically powerful ones.

Inequality within countries is fuelling the pandemic and putting those left behind and everybody else around the world at higher risk.

People from all layers of society in the most unequal countries (whether rich or poor), with inadequate public health services for less affluent people, have suffered the most. Middle class people have descended into situations of near destitution and poverty. This is happening in countries with large GDPs (the great pursuit of globalisation as we now it), such as the UK, as well as countries with low GDPs.

Covid-19 has also exacerbated inequality between countries as illustrated by the huge concentration of vaccines in richer economies while the rest of the world watches on.

Yet, this is a global health crisis involving an air-borne virus that travels the world around thanks to globalisation. In this case, the cliché is real and resonates among people the world over: nobody will be safe from the coronavirus until all people in all countries are.

Globalisation has gone so far that the question might not be whether it will survive, but rather, what will make it work for all. According to Joseph Stiglitz, globalisation could promote equality provided it was transparent, legitimate and accountable.

The challenge is to make globalisation favour full employment, social protection policies to protect living standards against economic shocks, universal quality health coverage, and perhaps most important of all, policies that reduce inequalities within and between countries.

Global health is so embedded into the engine of globalisation that it will be at the core of any reform of the economic order that might ensue from the pandemic.

I see three critical areas of positive change if global health was to reform because of Covid-19: a new global health balance of powers, a change in the laws and practices of international cooperation on health, and a popular movement for equality in the access to vaccines and equitable access to health in all countries.

  1. A new balance of powers in global health

According to WHO and UNAIDS, global health should be treated as a public universal good, with global governance structures which should not be dominated by the richer, more powerful countries. Yet, these very agencies are indeed at the mercy of the biggest economies that fund them. The dependency is even greater in the case of the Bretton Woods institutions: the IMF, the World Bank, and the World Trade Organisation (WTO). In global health, there is the additional dependency on multinational pharmaceutical companies, who control key global health supplies with patents largely protected under Intellectual Property regulations, a regime set out by WTO.

These dependencies contradict all the principles of change that would render globalisation a framework of equality. They do not favour transparency and these institutions are mostly only fully legitimate for and accountable to rich countries.

I wouldn’t hold my breath that powerful countries would want to give away their power in global health decisions. However, the balance of powers in global health may be changing. For example, the vaccine diplomacy of China (Sinovac vaccine) and Russia (Sputnik V vaccine) is making their Covid-19 vaccines available to lower income countries faster than vaccine-producing countries in the West. This diplomacy is increasing the popularity of these no longer emerging superpowers across many regions. Yet, as of early 2021, most countries were still negotiating with very little bargaining power their access to Vaxzevria (formerly AstraZeneca), Pfizer-BionTech, Moderna, and Johnson & Johnson Janssen, all of which were produced by Western multinationals with heavy public investment from European countries and the USA governments.

The new vaccine diplomacy might simply signal a change in who is dominating global health rather than a more equal distribution of powers across the board. But Mike O’Sullivan also sees a new multilateralism bringing countries together around shared values or interests. This has led to interesting initiatives such as Nordic countries and Southern Hemisphere countries acting together against climate change. These initiatives could be more transparent and accountable for more people living outside rich countries.

This trend could facilitate the creation of alliances among countries for which public health is a true public good and these countries could establish new global, albeit not universal, agreements and frameworks that advance global health as a public good in a good number of countries. Could there be room for an improbable alliance for health as a public good involving Cuba, the UK and Japan, for example?

  1. Changing laws and practices in global health cooperation

Reforming the laws and practices of international cooperation on health seems more straightforward given how abysmal such cooperation, or lack of, has been when confronting the Covid-19 pandemic. However, this might prove tricky. Global health legal and policy instruments are riddled with red lines set by states and corporations. In the end, big pharmaceutical companies’ interests, border control, and geopolitics often have the upper hand over public health needs, let alone the human right to health.

There is already a battery of legal instruments to regulate global health and foster collaboration to address health risks with the potential to threaten global security. These are mostly encapsulated in the WHO health regulations (IHR) introduced in 2005 and currently under review.

The IHR include requirements for the development of States Parties’ capacity to rapidly identify, report, and respond to potential public health emergencies of international concern. They also state that the responses must avoid unnecessary interference with human rights (although the IHR contemplate temporary derogation of human rights under some public health imperatives).

The IHR have not really worked well to respond to the Covid-19 pandemic.

It is therefore tempting to advocate for the current overhaul of IHR or the establishment of a new legal framework on pandemic suppression to radically change how the world responds to global health threats. For that, this instrument  would have to uphold the principle of health as a global common good, embracing the right to equality as the key paradigm for the prevention of pandemics.

For this to work, there needs to be wide political consensus across countries and have teeth: to be legally binding, to come with considerable funding to help countries collaborate and prepare for future pandemics and distribute the medical response to them equitably; and to set up strong accountability mechanisms to ensure monitoring and compliance.

If such new mechanism underpins the principles of health as a public good, and the human right to development, not just to health, it could help frame a response to the economic, social and environmental inequalities within and among countries that are the root cause of health inequality. With that framing, the mechanism could be particularly ambitious in the medical preparedness and response to pandemics, for example, with the suspension of vaccine patents in times of pandemic crisis and fair pre-established vaccine production and distribution schemes and economic recovery stimulus. If the mechanism is clear in its definitions, principles and enforcement measures, it has the potential of bringing levels of transparency and accountability that have not existed to date in global health.

Some countries are already calling for a Pandemics Treaty for preparedness and response. They demand an instrument that ensures “universal and equitable access to safe, efficacious and affordable vaccines, medicines and diagnostics for this and future pandemics”. This is a good starting point to make things change. But it sticks to the idea of promoting just health equality. Yet again, advancing a medicalised response to pandemics that falls short in addressing the root causes of health inequality: social, environmental and economic inequality within and between countries.

  1. A people’s movement to change priorities in global health

The problem with the two first areas of positive change I just mentioned is that they both very much depend on governments’ will. In the international arena, bold ideas often end up watered down by conflict of priorities, corporate interests, internal public opinion and diplomatic disputes.

Here is where the example of HIV and AIDS is most compelling. It was a global human rights campaign initiated in the US and Europe, but followed suit soon after in South Africa, India and many other countries that sparked the biggest global respond to a health threat ever to be seen. Herein lied a great deal of the legitimacy of the global HIV movement.

The argument that won this response was an outcry for the human right to live. Hundreds of thousands of people filling the streets and demanding access to treatment for those living with AIDS. A case for AIDS as a global security risk made at the UN Security Council and as a major public health threat warning by WHO came when the movement was well underway.

However, even though the HIV movement created its own global governance and has mobilised billions of dollars to safe millions of lives, it has not ended health inequality, and stigma, discrimination and human rights violations against marginalised populations affected by HIV: people who use drugs, the LGBT community, sex workers, young women and adolescent girls, among others.

This time, it will take a much bigger social movement to make the profound shift to bring about global equality in health. It will need to be an overwhelming force demanding accountability at all levels of the global health architecture. A truly global movement with legitimacy the word over, not a campaign dominated by civil society in the global north.

Will it be the #Peoplesvaccine campaign? It is early to say. In favour of this initiative, this pandemic is affecting every single person around the World. That was not the case with HIV. The campaign message is also compelling:  ‘pharmaceutical corporations must allow the Covid-19 vaccines to be produced as widely as possible by sharing their knowledge free from patents. Governments must facilitate such transfer of knowledge so that, when safe and effective vaccines are developed, they are produced rapidly at scale and made available for all people, in all countries, free of charge.’

Conclusion: time to make globalisation promote global health equality

Covid-19 and globalisation are inextricably linked. The virus has travelled all around the world at lightening speed facilitated by the free flow of people, a trait of globalisation. The pandemic has become a global health threat of utmost concern for the institutions governing globalisation, especially the Bretton Woods organisations, WHO and other UN agencies, and multilateral governmental fora, such as G-20.

Yet, Covid-19 is having a devastating impact on the lives of billions of people in both high and low-income countries. The pandemic has exacerbated deep economic, social, environmental and health inequalities within and between countries. It has also brutally exposed deep weaknesses in the current globalisation model and its instructions.

Critical changes are already underway in three key areas of global health with the combined potential of revolutionising globalisation as we know it. The balance of power in global health is changing with a new vaccine diplomacy; a growing number of governments are calling for a review of laws and policies framing preparedness and responses to global health threats, and a mounting mobilisation of civil society for a reconsideration of global health as a global good.

We have a historic opportunity to ensure these changes combine with the long-term objective of eliminating global economic, social, health and environmental inequalities. For that, the new globalisation institutions and legal and policy frameworks must be transparent, legitimate and accountable.

However, if governments, civil society, private actors and other key stakeholders take a short term, narrow vision, these changes are bound to perpetuate the inequalities that the current globalisation model has created. That will be the case if the new balance of power simply replaces exiting dominant governments and corporations for new ones, if the new legal and policy framework for pandemic preparedness just focuses on medical aspects ignoring economic, environmental and social inequality, and if the peoples’ vaccine campaign fizzles out once Covid-19 is under control in most countries.

 

 

 

 

 

 

News Flash 427: Weekly Snapshot of Public Health Challenges

News Flash Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

News Flash 427

Weekly Snapshot of Public Health Challenges

 

 

World Health Day 2021: did I miss something?

Policy Cures Research: webinar registration G-FINDER Launch Apr 15, 2021 01:00 PM in London

Webinar registration: “How do the 3Gs coordinate their efforts to strengthen health systems? From Policy to Practice” Apr 19, 2021 02:00 PM in Amsterdam

Regional Security in Times of Health Crisis – A Look at the East African Community by Becky Adiele 

Coronavirus disease (COVID-19) Weekly Update

A WHO senior official is under investigation in Italy

Chile and Uruguay, from model to emergency 

AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets 

COVID-19 Vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues 

South Africa halts J&J vaccine jabs; Europe rollout delayed 

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination 

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

2021 Public Forum (28 to 30 September) theme to be “Trade beyond COVID-19: Building Resilience”

Previous COVID-19 Infection Reduces Reinfection By 84%, Finds Lancet Study

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 April 2021

Chinese vaccines’ effectiveness low, official admits

Battling ‘supply constraints’, COVAX May Only Deliver 20% Of Vaccine Target By June

COVAX: A global multistakeholder group that poses political and health risks to developing countries and multilateralism 

COVAX reaches over 100 economies, 42 days after first international delivery 

In Brief: Lift export barriers to boost global vaccine supply, Moderna says

Access to Covid 19 vaccination only for the rich 

Online event: Big pharma: Your profits, our lives Wed, Apr 21, 2021, 6:00 PM –Thu, Apr 22, 2021, 7:00 PM CEST 

COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population 

Africa Plots Ambitious Vaccine Targets at Manufacturing Conference

HIV and TB Patients Face New Barriers To Accessing Services In COVID-19 Era

New WHO Global Compact to speed up action to tackle diabetes

MSF calls on WHO to prioritise supply of more quality-assured sources of insulin

Diabetes: Three dangerous myths that are hurting patients

Mali’s failure to ban FGM challenged in West Africa’s top court

Lo Stigma della siringa 

Shielding Corporate Interests, Europe Leaves NGOs Working in China by the Wayside 

Barilla Foundation Brings Health and Climate Together in New Double Pyramid 

NZ to launch world-first climate change rules

US envoy John Kerry woos China over climate

From 22-25 April 2021, the COP26 Coalition will host From the Ground Up: Taking Action, our second global gathering for climate justice

 

 

 

 

 

News Flash 426: Weekly Snapshot of Public Health Challenges

News Flash Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

News Flash 426

Weekly Snapshot of Public Health Challenges

 

 

POLITICAL DECLARATION OF THE HEALTH WORKERS FOR ALL COALITION

Webinar registration: “How do the 3Gs coordinate their efforts to strengthen health systems? From Policy to Practice”

Investing In Evidence To Inform Practice: Reimagining The US Public Health System

Rwanda Global Healthcare Summit: 9th to 11th August 2021 by Memory Usaman

Bundle of Joy or Cause for Shame? Just What Mothers in the Kenyan Informal Settlements Face. A Tale of Inequalities in Maternal Health Service Delivery by Reagun Andera Odhiambo 

Rohingyas, human rights and raising our voice

Promoting Women’s Economic Empowerment in the COVID-19 Context

Lessons for effective COVID-19 policy responses: a call for papers

How will COVID-19 transform global health post-pandemic? Defining research and investment opportunities and priorities

COVID-19, lies and statistics: corruption and the pandemic

Coronavirus disease (COVID-19) Weekly Update

AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets

Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety on AstraZeneca COVID-19 vaccine

Strong Link Between COVID-19 Infection & Mental Health Diagnoses – New Lancet Study

Brazil’s Supreme Court decision to amend national patent law could break lengthy monopolies on lifesaving medicines

WHO urges countries to build a fairer, healthier world post-COVID-19

U.S. puts J&J in charge of plant that botched COVID vaccine, removes AstraZeneca

Webinar registration: Conversation Series 2- Pandemics and Public Health: Learnings from the Past and Present April 16, 2021 Time: 06:30 PM – 08:30 PM IST 9:00 AM – 11:00 PM EDT

Vax-Covid. A passo di gambero

Haiti has no Covid vaccine doses as violence looms larger than pandemic

Uganda Green Lights Private Imports Of COVID-19 Vaccines – Kenya Nixes Similar Initiative

Kenya, expressing concern about counterfeit vaccines, blocks private imports of doses

Control of sexually transmitted infections and global elimination targets, South-East Asia Region

Eliminating mother-to-child transmission of human immunodeficiency virus, syphilis and hepatitis B in sub-Saharan Africa

The need for a new strategy for Ebola vaccination

Environmental burden of disease from unsafe and substandard housing, New Zealand, 2010–2017

The world report on hearing, 2021

A Healthy Indian Ocean Feeds, Protects, and Connects all South Asians

Indonesia’s Climate Villages Where Communities Work Together to Mitigate Climate Change

Impact of elevated air temperature and drought on pollen characteristics of major agricultural grass species

Ecological restoration of agricultural land can improve its contribution to economic development

‘Staggering’ scale of acute hunger in the Democratic Republic of the Congo